Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T77534
(Former ID: TTDI01761)
|
|||||
Target Name |
Phospholipase C (PLC)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | |||||
BioChemical Class |
Phosphoric diester hydrolase
|
|||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | D-20133 | Drug Info | Phase 1 | Solid tumour/cancer | [2] | |
Discontinued Drug(s) | [+] 1 Discontinued Drugs | + | ||||
1 | Phosphonate | Drug Info | Terminated | leukaemia | [3] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Inhibitor | [+] 2 Inhibitor drugs | + | ||||
1 | D-20133 | Drug Info | [1] | |||
2 | Phosphonate | Drug Info | [4] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Novel Inhibitors of AKT: Assessment of a Different Approach Targeting the Pleckstrin Homology Domain. Curr Med Chem. 2011; 18(18): 2727-2742. | |||||
REF 2 | Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133. Cancer Chemother Pharmacol. 1993;32(6):437-44. | |||||
REF 3 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004584) | |||||
REF 4 | Inhibition of phosphatidylinositol-specific phospholipase C by phosphonate substrate analogues. Biochim Biophys Acta. 1990 Feb 23;1042(3):410-2. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.